Invasive Streptococcus dysgalactiae subsp. equisimilis infections in a super-aged society: a Japanese nationwide observational study (2024–2025) Authors: Shigeo Hanada, Misako Takata, Miyuki Morozumi, Kiyofumi Ohkusu, Haruko Miyazaki, Satoshi Iwata, Kimiko Ubukata, Shigeki Nakamura Published: 2026 ABSTRACT AbstractBackgroundStreptococcus dysgalactiae subsp. equisimilis (SDSE), historically considered less virulent than Streptococcus pyogenes, has emerged as an important invasive pathogen, particularly in aging societies. Data on nationwide clinical and molecular epidemiology in super-aged populations remain limited. We aimed to identify admission abnormalities associated with the 28-day mortality for invasive SDSE (iSDSE) infections in Japanese adults and evaluate the molecular epidemiology of this emerging pathogen through a large-scale surveillance.MethodsA prospective nationwide surveillance of iSDSE was conducted between March 2024 and March 2025 in 132 hospitals across Japan. Clinical, epidemiological, and laboratory data, including emm type distribution, were collected and analyzed.ResultsOverall, 278 patients with iSDSE infections were identified (median age, 83 years); one-quarter of the patients were residents of long-term care facilities. Nearly all patients had comorbidities. The 28-day mortality was 12.2% overall, which increased to 16.1% among patients aged ≥ 80 years. Fatal outcomes were strongly associated with bacteremic pneumonia and streptococcal toxic shock syndrome, whereas cellulitis showed a lower mortality burden. Intensive care unit admission, mechanical ventilation, and vasopressor use were more common in patients with fatal outcomes, reflecting disease severity. Variables associated with poor outcome included leukopenia, thrombocytopenia, and elevated levels of C-reactive protein, creatinine, and creatine kinase. Emm typing revealed stG6792 as the predominant lineage; however, a marked increase of stG840 was observed. No significant outcome differences were noted across emm types.ConclusionsThese findings emphasize the combined impact of advanced age, comorbid conditions, and critical illness on iSDSE outcomes, highlight the clinical burden of iSDSE in older adults, and support continued monitoring in Japan.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-026-13453-w.Keywords: Emm type, Immunosenescence, Invasive infection, Long-term care facility, Older adults, Streptococcus dysgalactiae subsp. equisimilis Background Japan is one of the most aged societies in the world, with individuals aged 65 years or older accounting for 29.3% of the total population in 2024. This demographic shift has significant biological consequences, particularly age-related immune decline (immunosenescence). Immunosenescence impairs adaptive immunity by reducing antigen presentation by dendritic cells and lowering antibody production, compromising innate immunity. Additionally, aging induces a persistent state of low-grade systemic inflammation, often referred to as “inflammaging,” which further weakens immune resilience. These immunological changes increase susceptibility to infections among older adults, and when infections occur, the risks of severe disease and mortality are markedly higher [1, 2]. Invasive Streptococcus dysgalactiae subsp. equisimilis (iSDSE) infections have been increasingly reported in Japan, North America, and Northern Europe, reflecting a notable epidemiological shift [3–7]. SDSE is phylogenetically close to Streptococcus pyogenes (Group A Streptococcus, GAS), likely sharing a common ancestor. Recent large-scale genomic analysis has revealed extensive interspecies gene flow, including recombination of virulence and antimicrobial resistance determinants, which has blurred the genetic boundaries between the two pathogens [8]. Historically regarded as less clinically significant than GAS, SDSE is now recognized as an important pathogen, particularly in older populations [9–11]. SDSE has lower intrinsic virulence than GAS; however, our recent nationwide surveillance study conducted in Japan reported an overall 10% mortality in adults, with higher death rates among those aged ≥ 60 years [12]. Comparable outcomes have been observed in Finland, where malignancy, alcohol abuse, and dyspnea or altered consciousness at presentation were predictors of severe disease, and the overall 30-day case-fatality rate was 7.8% [13]. These findings highlight that host–pathogen immune interactions critically determine clinical outcomes. Understanding the clinical impact of iSDSE infections in aging societies such as Japan is important, especially with the increasing recognition of iSDSE among older adults and the need for context-specific epidemiologic monitoring. Accordingly, the aim of this study was to provide a descriptive report of the clinical and molecular epidemiology of iSDSE in Japan during a 1-year nationwide prospective surveillance period. Methods Ethical considerations This study followed the tenets of the Declaration of Helsinki and the Guidelines for Epidemiologic Studies issued by the Japanese Ministry of Health, Labor and Welfare. The study protocol was approved by the Institutional Review Board of the Tokyo Medical University Ethics Committee (approval number: T2020-0407). After obtaining informed consent from each patient, their medical records were obtained anonymously through a survey form completed by attending physicians. Study design This surveillance study was conducted to clarify the background characteristics of patients with iSDSE infections and the molecular epidemiological features of the isolates. Between March 2024 and March 2025, 132 general hospitals with clinical microbiology laboratories across Japan voluntarily participated in this surveillance study. Of the 132 participating hospitals, 84 (63.6%) were tertiary emergency care hospitals, and the remaining sites were community-based acute-care hospitals providing secondary-level emergency care (Figure S1). As this was a nationwide prospective surveillance study designed to include all eligible cases reported during the study period, no formal sample size calculation was performed. SDSE isolates and patient definition We analyzed data from patients aged ≥ 18 years with iSDSE infections. iSDSE infection was defined as the isolation of SDSE from normally sterile clinical samples, such as blood, cerebrospinal fluid, or closed pus. At each participating hospital, β-hemolytic streptococcal isolates belonging to Lancefield group C or G and suspected to be SDSE were sampled from a single colony using a sterile swab. The swab was placed into a sealed Bio-pouch and shipped to the central laboratory (Department of Microbiology, Tokyo Medical University) in a padded envelope. All received isolates were re-cultured, and species were identified via 16S rRNA gene sequencing. Underlying chronic disease was defined as the presence of diabetes mellitus; cardiovascular disease; active cancer (or receiving anticancer therapy); kidney disease (severe or moderate reduction in glomerular filtration rate [categories G4–5 or G3; Kidney Disease: Improving Global Outcomes classification]); immunocompromised conditions, such as rheumatoid arthritis, systemic lupus erythematosus, asplenia, and congenital immunodeficiency; hematological disorders; and use of high-dose immunosuppressive therapy (systemic corticosteroids at a daily dose equivalent to ≥ 10 mg of prednisolone for > 2 weeks) or biologic agents. Other comorbidities included liver disease and artificial joint replacement. Streptococcal toxic shock syndrome (STSS) was defined according to the STSS case definition described previously [14]. Emm typing Typing of the emm, encoding the M protein, was conducted using the polymerase chain reaction. After sequencing the amplified DNA fragments, emm types were identified using the Centers for Disease Control and Prevention emm sequence database (https://www2.cdc.gov/vaccines/biotech/strepblast.asp). Outcome ascertainment and denominators During the surveillance period, 278 cases were reported, and centralized emm typing was conducted for all available isolates; however, the 28-day outcomes were confirmed for 205 patients. Therefore, analyses requiring outcome status (survivor vs. non-survivor comparisons) were limited to these 205 cases. Statistical analysis Fatalities occurring within 28 days of admission were defined as deaths caused by or related to iSDSE infections. Associations among death, patient characteristics, and biomarkers were evaluated using logistic regression analysis to obtain odds ratios (ORs). Biomarkers were analyzed as binary variables after determining cutoff values in advance using receiver operating characteristic (ROC) analysis. Survival curves were plotted using the Kaplan–Meier method, and associations of white blood cell (WBC) count and other biomarkers with mortality were assessed. Statistical significance was defined as P < 0.05 (two-tailed test). All analyses were conducted using BellCurve for Excel (version 4.09; Social Survey Research Information Co., Ltd., Tokyo). Results Age distribution and outcome of patients with iSDSE infections During the surveillance period, data from 278 patients with iSDSE infections were collected, and the outcomes of 205 (73.7%) patients were determined. The median age of the patients with iSDSE infections was 83 years (interquartile range: 73–88 years). The number of patients was higher in the older age group, and the overall mortality was 12.2% (n = 25) (Fig. 1). The mortality rate among patients aged < 80 years ranged from 6.2% to 7.7%, whereas it increased to 16.1% (19/118) among patients aged ≥ 80 years. Furthermore, the number of patients diagnosed with STSS was extremely low (7 patients, 3.4%; survived, n = 2; died, n = 5). Age distribution and 28-day outcomes of adult patients with invasive Streptococcus dysgalactiae subsp. equisimilis infections. The stacked bars show the number of cases in each age group, categorized by streptococcal toxic shock syndrome (STSS) and the 28-day outcome. Colors indicate: STSS (died, red), STSS (survived, light blue), non-STSS (died, yellow), and non-STSS (survived, blue). Numbers in the legend (n=) indicate the total number of patients in each category across all age groups; numbers shown below each age group represent the total number of cases in that age group. Abbreviations: STSS, streptococcal toxic shock syndrome Clinical characteristics associated with outcome The patients with iSDSE infections were divided into survival (n = 180) and mortality (n = 25) groups, and a univariate analysis was performed to assess differences in demographic and clinical characteristics, including age, underlying diseases, clinical manifestations, and medical treatment (Table 1). Among the study population, 25.4% (49/193) were residents of long-term care facilities (LTCFs). Half of the patients living at home were aged ≥ 80 years, yet this age group accounted for as high as 81.7% among LTCF residents (Figure S2). Of the 169 patients with available information on comorbidities, 97.6% (n = 165) had underlying diseases. However, no specific comorbidity showed a significant difference in prevalence between the groups. Cognitive impairment was observed in 27.7% (48/172), and pressure ulcers or abrasions were present in 24.0% (40/167) (Fig. 2). The most frequent initial department of presentation was the emergency department, followed by internal medicine and dermatology (Figure S3). Table 1Characteristics of adult patients with invasive Streptococcus dysgalactiae subsp. equisimilis infections associated with fatal outcomesCharacteristicOverall(n = 205)Survival group(n = 180)Mortality group(n = 25)P-valueUnivariate analysisOR (95% CI) Age (years) < 703936 (92.3)3 (7.7)Ref 70‒794845 (93.8)3 (6.3)1.0000.8 (0.2‒4.2) ≥ 8011899 (83.9)19 (16.1)0.2872.3 (0.6‒8.3) Sex Male122103 (84.4)19 (15.6)Ref Female8377 (92.8)6 (7.2)0.0840.4 (0.2‒1.1) Residential status Living at home144128 (88.9)16 (11.1)Ref Living in a long-term care facility for older adults4940 (81.6)9 (18.4)0.2201.8 (0.7‒4.4) Underlying diseases ( n = 169) a 169 145 24 Underlying diseases and conditions 165141 (85.5)24 (14.5) Cardiovascular disease4335 (81.4)8 (18.6)0.4511.5 (0.6‒3.8) Diabetes mellitus3933 (84.6)6 (15.4)0.8011.1 (0.4‒3.0) Malignancy3730 (81.1)7 (18.9)0.4291.5 (0.6‒4.0) Cerebrovascular disease3024 (80.0)6 (20.0)0.3911.6 (0.6‒4.5) Immunocompromised2220 (90.9)2 (9.1)0.7450.6 (0.1‒2.5) Kidney disease2115 (71.4)6 (28.6)0.0892.8 (1.0‒8.1) Liver disease b97 (77.8)2 (22.2)0.6201.7 (0.3‒8.9) Pulmonary disease87 (87.5)1 (12.5)1.0000.8 (0.1‒7.1) Others3933 (84.6)6 (15.3)0.7450.6 (0.1‒2.5) Cognitive function Normal124111 (89.5)13 (10.5)Ref Dementia or cognitive impairment4844 (91.7)4 (8.3)0.7820.8 (0.2–2.5) Skin integrity Intact127115 (90.6)12 (9.4)Ref Abrasions and/or pressure ulcers4035 (87.5)5 (12.5)0.5581.4 (0.5–4.2) Initial department of presentation Emergency8470 (83.3)14 (16.7)Ref Internal Medicine5246 (88.5)6 (11.5)0.4650.7 (0.2–1.8) Dermatology2625 (96.2)1 (3.8)0.1140.2 (0.0–1.6) Others4339 (90.7)4 (9.3)0.2970.5 (0.2–1.7) Clinical manifestations Cellulitis7066 (94.3)4 (5.7) 0.045 0.3 (0.1‒1.0) Bacteremia without primary focus6559 (90.8)6 (9.2)0.4930.6 (0.2‒1.7) Urosepsis2019 (95.0)1 (5.0)0.4780.4 (0.0–2.8) Bacteremic pneumonia1712 (70.6)5 (29.4) 0.040 3.5 (1.1‒11.0) Septic arthritis88 (100)00.599‒ Toxic shock syndrome c72 (28.5)5 (71.4) < 0.001 22.3 (4.0‒122.2) Osteomyelitis/spondylitis66 (100)01.000‒ Soft-tissue infection4310.4082.5 (0.2‒24.6) Necrotizing fasciitis3210.3243.7 (0.3‒42.5) Peritonitis312 0.040 15.6 (1.4–178.5) Others d2201.000‒ Medical treatment ( n = 195) 195 170 25 ICU admission1913 (68.4)6 (31.6) 0.021 3.8 (1.3‒11.2) Mechanical ventilation158 (53.3)7 (46.7) < 0.001 7.9 (2.6‒24.2) Vasopressor169 (56.3)7 (43.8) 0.001 7.0 (2.3‒20.9) Renal replacement therapy110‒‒a Presence or absence of an underlying disease could be determined in 169 patients, excluding 36 patients with unknown outcomes. Of these, 165 (97.6%) had underlying diseases, including overlapping patientsb Includes chronic hepatitis or cirrhosis secondary to alcohol abuse or viral infectionc Includes a patient with rhabdomyolysisd Includes meningitis and empyemaAbbreviations: OR, odds ratio; CI, confidence interval; ICU, intensive care unit Characteristics of adult patients with invasive Streptococcus dysgalactiae subsp. equisimilis infections associated with fatal outcomes a Presence or absence of an underlying disease could be determined in 169 patients, excluding 36 patients with unknown outcomes. Of these, 165 (97.6%) had underlying diseases, including overlapping patients b Includes chronic hepatitis or cirrhosis secondary to alcohol abuse or viral infection c Includes a patient with rhabdomyolysis d Includes meningitis and empyema Abbreviations: OR, odds ratio; CI, confidence interval; ICU, intensive care unit Proportion of long-term care facility residents, those with cognitive impairment, and those in care-dependent conditions Cellulitis, bacteremia without a primary focus, urosepsis, and bacteremic pneumonia were the most common syndromes, accounting for 34.1% (n = 70), 31.7% (n = 65), 9.8% (n = 20), and 8.3% (n = 17), respectively. In univariate analyses, STSS, bacteremic pneumonia, and peritonitis were associated with a high 28-day mortality burden, whereas cellulitis exhibited a lower mortality burden compared with that of severe presentations. Intensive care unit admission, mechanical ventilation, and vasopressor use were more frequent among patients with fatal outcomes, indicating greater disease severity. We observed no apparent seasonal trend in case occurrence during the 1-year study period. Association of laboratory findings with outcome Based on biomarker cutoff values, the significant differences between the survival and mortality groups and the ORs and 95% confidence intervals (CIs) were calculated (Table 2). Patients with a WBC count < 4 × 103 cells/µL or a platelet count (PLT) < 10 × 104 cells/µL on admission had significantly higher ORs for mortality. Elevated C-reactive protein (CRP, ≥ 20 mg/dL), aspartate aminotransferase (≥ 100 IU/L), blood urea nitrogen (BUN, ≥ 30 mg/dL), serum creatinine (Cr, ≥ 2.0 mg/dL), and creatine kinase (CK, ≥ 300 IU/L) levels were also more frequent in the mortality group versus the survival group. The ROC curves of the biomarkers are shown in Figure S4. Table 2Laboratory findings and outcomes in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infectionBiomarker(Cut-off value)Survival group (n = 180)Mortality group (n = 25)P-valueOR (95% CI)No. of patientsassessedMedian (IQR) n (%)No. of patients assessedMedian (IQR) n (%)WBC count (× 103 cells/µL)17011.5 (8.3‒15.5)258.9 (2.6‒12.9)(< 4 × 103 cells/µL)13 (7.6)8 (32.0) 0.002 5.7 (2.1–15.7) PLT count (× 104 cells/µL)16915.5 (11.1‒20.9)259.5 (7.3‒16.5)(< 10 × 104 cells/µL)30 (17.8)13 (52.0) < 0.001 5.0 (2.1–12.1) CRP level (mg/dL)1697.9 (1.7‒19.7)2519.4 (7.4‒28.8)(≥ 20 mg/dL)41 (24.3)12 (48.0) 0.017 2.9 (1.2–6.8) AST level (U/L)14327 (20‒44)2340 (27‒109)(≥ 100 U/L)15 (10.5)8 (34.8) 0.005 4.6 (1.7–12.5) BUN level (mg/dL)15723 (16‒32)2244 (30‒69)(≥ 30 mg/dL)52 (33.1)17 (77.3) < 0.001 7.5 (2.6–21.3)Cr level (mg/dL)1671.0 (0.8‒1.4)241.9 (1.4‒2.8)(≥ 2.0 mg/dL)19 (11.4)12 (50.0) < 0.001 7.8 (3.1–19.8) CK level (U/L)157115 (65‒218)22136 (57‒1939)(≥ 300 U/L)30 (19.1)9 (40.9) 0.028 2.9 (1.1–7.5) Abbreviations: OR, odds ratio; CI, confidence interval; IQR, interquartile range; WBC, white blood cell; PLT, platelet; CRP, C-reactive protein; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; CK, creatine kinase Laboratory findings and outcomes in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infection Abbreviations: OR, odds ratio; CI, confidence interval; IQR, interquartile range; WBC, white blood cell; PLT, platelet; CRP, C-reactive protein; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; CK, creatine kinase Biomarker level and death in relation to the time elapsed after admission Kaplan–Meier curves were used to descriptively represent the 28-day survival after admission, categorized by admission laboratory results (WBC and PLT, and Cr and BUN levels) (Fig. 3). Leukopenia (WBC count < 4,000 cells/µL), thrombocytopenia (PLT < 10 × 104 cells/µL), and renal dysfunction (Cr ≥ 2.0 mg/dL and/or BUN ≥ 30 mg/dL) were associated with decreased 28-day survival (log-rank test, P < 0.001). Among patients with leukopenia at admission, a larger proportion of deaths occurred within the first 4 days. Timing of death and 28-day survival stratified by admission biomarkers in invasive Streptococcus dysgalactiae subsp. equisimilis (iSDSE). (a) Distribution of time from hospital admission to death among patients who died within 28 days (n = 25). (b) Kaplan–Meier estimates of 28-day survival after admission stratified by admission laboratory categories: leukopenia (WBC < 4,000/µL) vs. ≥ 4,000/µL, thrombocytopenia (platelet count < 10 × 10⁴/µL) vs. ≥ 10 × 10⁴/µL, renal dysfunction by creatinine (≥ 2.0 mg/dL vs. < 2.0 mg/dL), and by blood urea nitrogen (BUN ≥ 30 mg/dL vs. < 30 mg/dL). P-values were calculated using the log-rank test. Abbreviations: BUN, blood urea nitrogen; Cr, creatinine; PLT, platelet count; WBC, white blood cell count Association between emm type and patient prognosis Figure 4 shows the distribution of emm types in the survival and mortality groups, including the patients with unknown outcomes. Consistent with previous reports from Japan [12], stG6792 was the most prevalent emm type among the SDSE isolates; however, a marked increase in stG840 was observed. No significant differences in poor outcomes were identified across the emm types. Relationship between emm types of isolates and outcomes. stG6792 is the most prevalent emm type among the SDSE isolates; however, a marked increase in stG840 is observed. No significant differences in the proportion of poor outcomes are identified across the emm types Clinical and laboratory features of patients with fatal iSDSE infections Table S1 summarizes the baseline characteristics and laboratory findings of 25 patients with fatal iSDSE infections. These patients were predominantly older adults and had multiple comorbidities. The most frequent clinical manifestations included bacteremic pneumonia, cellulitis, bacteremia without a primary focus, and STSS. The most common emm type was stG6792 (n = 6). However, there was no trend indicating a more common incidence of a particular emm type among the patients with fatal infections. Laboratory findings at admission commonly demonstrated elevated inflammatory markers (CRP), impaired renal function (increased BUN and Cr), and elevated CK, particularly in patients with necrotizing fasciitis or myositis. In fatal cases, laboratory abnormalities were characterized by elevated inflammatory markers and signs of organ dysfunction at presentation (Table S1). Discussion Invasive infections caused by SDSE are increasingly recognized worldwide, particularly among older adults with multiple comorbidities [3, 6, 7, 9, 10, 15–17]. The median age of our cohort was 83 years, which is higher than that reported in nationwide Japanese studies [4, 5, 12, 17, 18], and our cohort was older than those reported in studies from Europe and North America [6, 7, 10, 15, 19]. This is consistent with national surveillance of SDSE-associated STSS in Japan, which reported that affected patients were the oldest among those with β-hemolytic streptococcal infections and that fatality increased significantly with age [20]. In Japan, our molecular epidemiologic investigations have revealed a significant increase in the median age of patients with iSDSE, from 75 years in 2006 to 83 years in 2024 (Figure S5). Overall, these observations highlight that iSDSE in Japan is primarily observed among older adults in the context of a super-aged society [1, 11]. This temporal shift may partly reflect population aging and the increasing number of individuals reaching advanced age; however, we did not conduct population-based analyses using age-stratified denominator data (life expectancy). A subset of iSDSE cases in our cohort occurred among residents of LTCFs [21]. This observation may be consistent with differences in host vulnerability and facility-level context between LTCF residents and community-dwelling patients. In our cohort, approximately one-quarter of patients resided in LTCFs; these residents were generally older than those living in the community and more frequently displayed frailty-related characteristics, as shown in Fig. 2. This figure shows the composite vulnerability profile of the affected population, rather than isolating independent predictors of bacteremia or mortality. Immunosenescence and comorbidities increase susceptibility to invasive infection [1, 2, 6, 9]. Cognitive impairment and care dependency (Fig. 2) may be associated with swallowing dysfunction and aspiration risk, potentially allowing oral/pharyngeal microbiota to enter the bloodstream; however, these mechanisms were not directly assessed in this study [21]. Pressure ulcers, chronic edema, and dermatological conditions can also serve as entry points for cellulitis and bloodstream infection [3, 7]. Here, “facility-related environmental factors” refers to non-airborne, potentially modifiable facility-level conditions that may increase the risk of infection among vulnerable residents. Examples include variation in oral hygiene, wound management, and device use (indwelling urinary catheters) [10, 18, 22]. Furthermore, shared caregiving contact networks and other structural/operational features of LTCFs may increase the risk of exposure among residents; however, our dataset does not allow an evaluation of intra-facility transmission [23]. A recent report of invasive group G Streptococcus in a skilled nursing facility shows that facility-level factors may warrant consideration in vulnerable older populations [24]. Intra-facility spread or the impact of facility-level interventions cannot be evaluated in this study. Future studies linking molecular epidemiology with detailed clinical and facility-level data may help generate hypotheses regarding transmission pathways and inform targeted investigations [8, 10, 23, 25]. In our study, the proportion of the emm type stG840 increased notably, whereas stG6792 remained the most frequent type, consistent with previous Japanese studies [4, 5, 12, 26]. Compared with our prior nationwide study [5, 12, 17], stG840 increased from 0% (n = 0) to 17.6% (n = 49/278) in the current cohort (among isolates with available emm typing), whereas the three most common emm types remained unchanged (stG6792, stG485, and stG245). Together with the temporal comparison across prior surveillance periods shown in Figure S6, these findings suggest a recent increase in the frequency of stG840 in Japan. Previous domestic investigations consistently identified stG6792 as the predominant lineage among iSDSE isolates, whereas stG840 had been reported only in a limited subset of isolates. In a regional multicenter study of SDSE bacteremia in western Japan (Kyoto–Shiga region) between 2005 and 2021, stG840 accounted for approximately 11% of isolates and was observed exclusively among ST525 isolates [18]. In the present cohort, stG840 was identified across multiple regions of Japan rather than being confined to western Japan, indicating that this lineage was observed in more than one region during the current surveillance period [27]. Genetic heterogeneity has also been reported in Taiwan, Korea, and Europe, where distinct emm repertoires and clonal complexes have been described [28–30]. In Europe, the expansion of stG62647 within clonal complex (CC20) has been documented in a recent Spanish surveillance study [30]. These international reports provide context for regional diversity in circulating SDSE lineages; however, the present study was not designed to evaluate dissemination pathways, and our findings should therefore be interpreted as descriptive temporal and geographic observations within Japan. Emm typing is a practical approach for describing lineage distributions in nationwide surveillance. However, because emm typing has limited discriminatory power, it cannot by itself establish transmission links or identify facility-based clusters. Such questions require integration with epidemiologic data and, where feasible, higher-resolution genomic methods such as whole-genome sequencing. In the present study, molecular surveillance was useful primarily for documenting lineage distribution and temporal changes in circulating emm types within Japan. Overall, the observed increase in stG840 supports continued monitoring in Japan to better define its clinical and epidemiologic significance. In our prior nationwide study [12], multivariable analysis identified advanced age, severe disease, bacteremia without a primary focus (compared to cellulitis), renal dysfunction, elevated CK, and macrolide resistance as independent predictors of mortality. In the current 1-year cohort, the limited number of fatal events precluded robust multivariable modeling; therefore, direct comparisons of adjusted risk-factor profiles across periods should be interpreted with caution. Accordingly, the survival analyses in this cohort should be interpreted as descriptive representations of severity at presentation rather than identification of novel prognostic predictors. Nevertheless, this cohort was predominantly composed of older adults and included approximately one-quarter of LTCF residents, which likely contributed to the modestly higher observed crude mortality relative to our previous study. Importantly, our univariate results reaffirm that early markers of systemic severity at presentation—particularly renal dysfunction and cytopenias—identify patients at high risk of rapid deterioration, consistent with the overall prognostic framework described in the previous study [12]. This study has certain limitations. First, the 28-day outcomes were available for 205 of 278 reported cases. Consequently, the outcome-based analyses were limited to cases with confirmed outcomes, which may have introduced selection bias. However, the emm-type distribution among cases without available outcome data was similar to that of cases with known outcomes, indicating no apparent emm-type bias attributable to missing outcomes information. Second, because of its observational design, treatment may not have been allocated according to disease severity. Given the advanced age of many patients, some critically ill patients may not have received intensive care, which could have contributed to the higher observed mortality. Third, the limited sample size and number of fatal outcomes (25 deaths) restricted the precision of mortality analyses and precluded robust multivariable modeling to further define associations between patient characteristics, bacterial factors, and mortality. Fourth, symptom-onset and treatment-initiation data were not collected in a standardized manner across sites; therefore, we could not evaluate the prognostic impact of time-to-presentation or time to effective antibiotic therapy. Fifth, comparisons among invasive streptococcal groups (iGAS, iGBS, and iSDSE) using longitudinal surveillance would provide deeper insights into shared and species-specific clinical phenotypes and outcomes; however, such analyses were beyond the scope of this single-year, organism-focused iSDSE study. Finally, it was not feasible to fully evaluate relationships between LTCF residence and emm type because data on LTCFs were incomplete. These limitations warrant confirmation through large-scale nationwide surveillance studies. Conclusions This nationwide molecular epidemiological study showed that patients with iSDSE infections in Japan were predominantly older adults, including approximately one-quarter residing in LTCFs. Mortality analyses in this cohort were descriptive and indicated that fatal outcomes were associated mainly with severe clinical presentation and organ dysfunction at admission. In parallel, emm typing documented the circulating lineage distribution and a recent increase in stG840 in Japan. Future studies integrating clinical, epidemiologic, and higher-resolution molecular data are needed to better characterize iSDSE in older adults and long-term care populations. Electronic Supplementary Material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Acknowledgements The authors would like to thank the laboratory staff and physicians who participated in this surveillance activity; Shigeaki Ohtsuki, PhD, a representative of the Japan Institute of Statistical Technology, for providing support in the statistical analysis; and Editage (www.editage.com) for English language editing. Abbreviations Blood urea nitrogen Confidence interval Creatine kinase Creatinine C-reactive protein Group A Streptococcus invasive Streptococcus dysgalactiae subsp. equisimilis long-term care facility Odds ratio Platelet Receiver operating characteristic Streptococcus dysgalactiae subsp. equisimilis streptococcal Toxic shock syndrome White blood cell Author contributions SH, KU, and SN are the chief investigators responsible for organizing the study. MT, MM, KO, HM, and SI were responsible for the coordination of this study, including the genotyping of Streptococcus dysgalactiae subsp. equisimilis and were responsible for data analysis and manuscript drafting. All the authors read and approved the final manuscript. Funding Not applicable. Data availability Raw sequencing data consist only of short amplicons used for emm typing and do not fall under the categories of mandated data deposition. These data cannot be made publicly available due to ethical and confidentiality considerations. Reasonable requests for further information may be directed to the corresponding author. Declarations Ethics approval and consent to participate This study was performed in line with the principles of the Declaration of Helsinki. Approval was obtained from the Institutional Review Board of the Tokyo Medical University Ethics Committee (approval number: T2020-0407). Informed consent was obtained from each patient. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Shigeo Hanada, Kimiko Ubukata and Shigeki Nakamura contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Data Availability Statement Raw sequencing data consist only of short amplicons used for emm typing and do not fall under the categories of mandated data deposition. These data cannot be made publicly available due to ethical and confidentiality considerations. Reasonable requests for further information may be directed to the corresponding author.